Literature DB >> 485720

Effects of cytidine-5' diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain.

M Martinet, P Fonlupt, H Pacheco.   

Abstract

Administered intravenously to rats, CDPcholine, significantly increases the level and the synthesis rate of dopamine, and the level of tyrosine in the corpus striatum (maximum effect for 50 mg/kg, one hour after administration). CDPcholine decreases the level of serotonin and tryptophan and the synthesis rate of serotonin in the midbrain + hypothalamus and in the brain stem. The increase of the striatum dopamine level and the decrease of the brain stem and midbrain serotonin level are correlated with the recognized antiparkinson and neurostimulant action of this nucleotide.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485720

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  14 in total

Review 1.  Citicoline in addictive disorders: a review of the literature.

Authors:  Nicholas D Wignall; E Sherwood Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2014-06-20       Impact factor: 3.829

2.  Open-label uridine for treatment of depressed adolescents with bipolar disorder.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Delmastro; Eun-Kee Jeong; Namkug Kim; Xianfeng Shi; Perry F Renshaw
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-12       Impact factor: 2.576

3.  Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers.

Authors:  Stephanie C Licata; David M Penetar; Caitlin Ravichandran; John Rodolico; Christopher Palmer; Jeff Berko; Thomas Geaghan; Alison Looby; Erica Peters; Elizabeth Ryan; Perry F Renshaw; Scott E Lukas
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

4.  Uptake and utilization of CDP-choline in primary brain cell cultures from fetal brain.

Authors:  A Vecchini; L Binaglia; A Floridi; C A Palmerini; G Procellati
Journal:  Neurochem Res       Date:  1983-03       Impact factor: 3.996

5.  Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study.

Authors:  Sujung J Yoon; In Kyoon Lyoo; Hengjun J Kim; Tae-Suk Kim; Young Hoon Sung; Namkug Kim; Scott E Lukas; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

6.  Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control.

Authors:  Yolandi van der Merwe; Matthew C Murphy; Jeffrey R Sims; Muneeb A Faiq; Xiao-Ling Yang; Leon C Ho; Ian P Conner; Yu Yu; Christopher K Leung; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

Review 7.  Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives.

Authors:  Gloria Roberti; Lucia Tanga; Manuele Michelessi; Luciano Quaranta; Vincenzo Parisi; Gianluca Manni; Francesco Oddone
Journal:  Int J Mol Sci       Date:  2015-11-30       Impact factor: 5.923

Review 8.  Neuroprotective agents in the management of glaucoma.

Authors:  C Nucci; A Martucci; C Giannini; L A Morrone; G Bagetta; R Mancino
Journal:  Eye (Lond)       Date:  2018-02-23       Impact factor: 3.775

Review 9.  Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function.

Authors:  Vincenzo Parisi; Francesco Oddone; Lucia Ziccardi; Gloria Roberti; Gianluca Coppola; Gianluca Manni
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 10.  Rational Basis for Nutraceuticals in the Treatment of Glaucoma.

Authors:  Luigi Antonio Morrone; Laura Rombola; Annagrazia Adornetto; Maria Tiziana Corasaniti; Rossella Russo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.